Jiangsu Hengrui Medicine
600276.SS
#504
Rank
$40.87 B
Marketcap
$6.41
Share price
0.39%
Change (1 day)
-0.34%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : $0.57 Billion USD

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total liabilities are $0.57 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Jiangsu Hengrui Medicine - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31$0.57 B-1.42%
2021-12-31$0.57 B-4.09%
2020-12-31$0.60 B61.24%
2019-12-31$0.37 B-0.32%
2018-12-31$0.37 B16.73%
2017-12-31$0.32 B53.7%
2016-12-31$0.20 B19.29%
2015-12-31$0.17 B16.62%
2014-12-31$0.15 B61.57%
2013-12-31$93.26 M29.21%
2012-12-31$72.17 M3.22%
2011-12-31$69.92 M9.88%
2010-12-31$63.63 M30.2%
2009-12-31$48.87 M44.84%
2008-12-31$33.74 M-38.86%
2007-12-31$55.19 M114.26%
2006-12-31$25.75 M17.35%
2005-12-31$21.95 M-29.48%
2004-12-31$31.12 M-52.98%
2003-12-31$66.2 M38.88%
2002-12-31$47.67 M9.29%
2001-12-31$43.62 M